DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients
NCT02834468
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Immune Thrombocytopenia
Interventions
DRUG:
DEX Combined With RTX, CSA and IVIG
Sponsor
Shandong University
Collaborators
[object Object]
[object Object]
[object Object]